期刊文献+

慢病毒介导的红色荧光蛋白基因在大鼠坐骨神经细胞的表达 被引量:1

Lentiviral vector-mediated transfection of RFP Gene into rat sciatic nerve cells
原文传递
导出
摘要 目的 研究慢病毒载体介导的红色荧光蛋白(RFP)基因在坐骨神经雪旺细胞体内转染情况.方法 将60只Wistar大鼠随机分成A组、B组、C组和D组四个组,每组15只.四组均行右坐骨神经损伤模型,术毕向B组、C组和D组坐骨神经内注入滴度分别为2×10-6 TU、2×10-7 TU、2×10-8 TU的Lenti-RFP悬液8μl,向A组注入8μl平衡盐液(BSS)作为对照组.术后第1、2、4周观察红色荧光蛋白的表达情况,计算转染效率;并进行神经组织学检查.结果 术后第1周B、C、D组均出现RFP表达,术后第4周D组的转染效率最高.同一时间不同滴度组以及同一滴度组不同时间比较差异有统计学意义(P<0.05).组织学检查病毒载体对神经未见明显炎性反应及组织学损伤.结论 慢病毒载体能安全有效的在体内转染雪旺细胞,并有浓度依赖性和时间依赖性,对组织无明显毒性作用. Objective To investigate the expression of RFP in Schwann cell of rat sciatic nerve transfected with lentivirus vetor.Methods Sciatic nerve injury model was established by transection of right sciatic nerve in 60 female wistar rats that were then randomly divided into 4 groups:group A,B,C and D.At the end of the procedure,8μl of Lenti-RFP suspension (2× 10-6 TU,2 × 10-7 TU,2 × 10-8 TU) were injected into the sciatic nerve of the rats in group B,C and D,respectively.The rats in group A received 8μl of balanced salt solution (BSS) and were used as the control.In the 1st,2nd and 4th week after the surgery,the expression of RFP and the effects of lentivirus vetor on Schwann cells were tested,and the transfection efficiency was calculated.Results RFP gene expressions were observed in Group B,C and D one week after surgery,and the highest transfection efficiency were found in group D at the 4th week after surgery..Statistically significant differences of transduction efficiency were observed in the different dosage groups at the same time,or in the same group at different time.The histological damage to sciatic nerve caused by the vector was not obvious in every group.Conclusions RFP gene can be transfected into Schwann cells in vivo with stable and efficient expression.Clear dosage-dependent and time-dependent features were observed.Lentivirus vector caused no histological damage to sciatic nerve.
出处 《国际病毒学杂志》 2014年第6期266-269,共4页 International Journal of Virology
关键词 慢病毒载体 红色荧光蛋白 基因转导 Lentiviral vector Red fluorescent protein Gene transduction
  • 相关文献

参考文献9

  • 1黄海涛,刘华蔚,胡敏.神经营养因子促周围神经再生的研究进展[J].神经解剖学杂志,2013,29(5):599-602. 被引量:16
  • 2Wang Y, Shen W, Yang L, et al. The protective effects of Achy- ranthes bidentata polypeptides on rat sciatic nerve crush injury causes modulation of neurotrophic factors [ J]. Neurechem Res,2013, 38(3): 538-546.
  • 3史晨辉,王维山,李长俊,张振东,郭风劲,陈安民.慢病毒介导uPA-siRNA重组表达载体的构建及促进兔软骨细胞增殖[J].基础医学与临床,2014,34(5):602-609. 被引量:5
  • 4Kim BK, Seu YB, Bae YU, et al. Efficient delivery of plasmid DNA using cholesterol-based cationic lipids containing polyamines and ether linkages[ J]. Int J Mol Sci, 2014, 15(5) : 7293-7312.
  • 5Yaguchi M, Ohashi Y, Tsubota T, et al. Characterization of the properties of seven promoters in the motor cortex of rats and mon- keys after lentiviral vector-mediated gene transfer [ J ]. Hum Gene Ther Methods, 2013, 24(6) : 333-344.
  • 6Frecha C, Costa C, Negre D, et al. A novel lentiviral vector tar- gets gene transfer into human hematopoietic stem cells in man'ow from patients with bone marrow failure syndrome and in vivo in hu-manized mice[J]. Blood, 2012, 119(5): 1139-1150.
  • 7Kato S, Kuramochi M, Takasumi K, et al. Neuron-specific gene transfer through retrograde transport of lentiviral vector pseudotyped with a novel type of fusion envelope glycoprotein [ J ]. Hum Gene Ther, 2011, 22(12) : 1511-1523.
  • 8Roybal JL, Endo M, Radu A, et al. Early gestational gene trans- fer of IL-IO by systemic administration of lentiviral vector can pre- vent arthritis in a murine model[ J]. Gene Ther, 2011, 18 (7) :719 -726.
  • 9Oliveira LA, Kim C, Sousa LB, et al. Gene transfer to primary corneal epithelial cells with an integrating lentiviral vector [ J l- Arq Bras Oftalmol, 2010, 73(5) : 447-453.

二级参考文献34

  • 1Ascano M, Bodmer D, Kuruvilla R. Endocytic trafficking of neuro- trophins in neural development [ J ]. Trends Cell Biol, 2012, 22: 266 - 273.
  • 2] Shakhbazau A, Martinez JA, Xu QG, et al. Evidence for a systemic regulation of neurotrophin synthesis in response to peripheral nerve injury[J]. JNeurochem, 2012, 122:501 -511.
  • 3Gordon T. The physiology of neural injury and regeneration : the role of neurotrophic factors [ J]. J Commun Disord, 2010, 43 : 265 - 273.
  • 4Xu H, Yan Y, Li S. PDLLA/chondroitin sulfate/chitosan/NGF conduits for peripheral nerve regeneration [ J ]. Biomaterials, 2011, 32:4506 -4516.
  • 5Allodi I, Udina E, NavarroX. Specificity of peripheral nerve regen- eration : Interactions at the axon level E J 1. Prog Neurobiol, 2012, 98:16 -37.
  • 6Madduri S, Gander B. Growth factor delivery systems and repair strategies for damaged peripheral nerves [ J ]. J Control Release, 2012, 161:274 - 282.
  • 7Daly W, Yao L, Zeugolis D, et al. A biomaterials approach to pe- ripheral nerve regeneration: bridging the peripheral nerve gap and enhancing functional recovery[ J]. J R Soc Interface, 2012, 9:202 -221.
  • 8Fu SY, Gordon T. The cellular and molecular basis of peripheral nerve regeneration[ J]. Neurobiol, 1997, 14:67 - 116.
  • 9Ichim G, Tauszig-Delamasure S, Mehlen P. Neurotrophins and cell death[J]. Exp Cell Res, 2012, 318:1221 -1228.
  • 10Ferguson TA, Son YJ. Extrinsic and intrinsic determinants of nerve regeneration[ J]. J Tissue Eng, 2011, 2:1 - 12.

共引文献19

同被引文献22

  • 1World Health Organization. 2005. WHO Expert Committee on Ra-bies. 2004. First Report; WHO technical report series 931. World Health Organization. Geneva, Switzland.
  • 2Wilfred E, Marissen R, Arjen K, et al. Novel rabies virus- neu- tralizing epitope recognized by human monoclonal antibody: fine mapping and escape mutant analysis[J]. J Virol, 2005, 79(8) : 4672-4678.
  • 3Kader M, Shampur NM, Vasanthapuram R. Development and e- valuation of a competitive ELISA for estimation of rabies neutrali- zing antibodies after post-exposure rabies vaccination in humans [J]. Int J Infect Dis, 2007, 11(5) 441-445.
  • 4Naldini L, Blomer U, Gallay P, et al. In vtvo gene delivery and stable transduetion of nondividing cells by a lentiviral vector [ J ]. Science, 1996, 272 (5259) : 263-267.
  • 5Dull T, Zufferey R, Kelly M, et al. A third-generation lentivirus vector with a conditional packaging system[J]. J Virol, 1998, 72 ( 11 ) : 8463-8471.
  • 6Pluta K, Kacprzak MM. Use of HIV as a gene transfer vector[ J]. Acta biochimica polonica, 2009, 56(4) : 531-595.
  • 7Mazarakis ND, Azzouz M, Rohll JB, et ah Rabies virus glycopro- tein pseudotyping of lentiviral vectors enables retrograde axonal transport and access to the nervous system after peripheral delivery [J]. Hum Mol Genet, 2001, 10(19) : 2109-2121.
  • 8Wright E, Temperton NJ, Marston DA, et al. Investigating anti- body neutralization of lyssaviruses using lentiviral pseudotypes : a cross-species comparison [ J ]. J Gen Virol, 2008, 89 ( Pt9 ) : 2204-2213.
  • 9Edward W, Suzanne M, Trudy G, et ah A robust lentiviral pseudotype neutralisalion assay for in-field serosurveillanee of ra- bies and lyssaviruses in Africa [ J ]. Vaccine, 2009, 27 ( 51 ) : 7178-7186.
  • 10Bakker AB, Marissen WE, Kramer RA, et al. Novel human monoelonal antibody combination effectively neutralizing natural rabies virus variants and individual in vitro escape mutants [ J ]. J Virol, 2005, 79(14): 9062-9068.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部